PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
11-Dec-2025 Xinnate Receives FDA IND Approval for TCP-25, Enabling Pivotal Phase 2/3 STEP Study in Epidermolysis Bullosa Xinnate
11-Dec-2025 Fibrocor Therapeutics appoints world-leading nephrologists to Clinical Advisory Board with a focus on its lead indication Alport Syndrome Fibrocor Therapeutics
11-Dec-2025 ProBioGen and Spica Therapeutics Announce Collaboration on GlymaxX-Enhanced CLD for Spica’s Clinical Development Candidate ST101 ProBioGen and Spica Therapeutics
11-Dec-2025 WORLD’S LEADING ANTIMALARIAL PRODUCT DEVELOPMENT PARTNERSHIP JOINS IICON CONSORTIUM IICON CONSORTIUM
11-Dec-2025 VPAG payment rate for newer medicines will be 14.5% in 2026 VPAG
11-Dec-2025 Perceptive eClinical Recognized as #1 Market Impact, and Overall, Leader in Everest Group’s PEAK Matrix® Assessment for RTSM Solutions 2025 Perceptive eClinical
11-Dec-2025 Mabylon AG Initiates Phase I Clinical Trial of Lead Compound MY006 for the Treatment of Peanut Allergy Mabylon AG
10-Dec-2025 Mindpeak Secures First Patent for Advanced AI Method in Digital Pathology Mindpeak
10-Dec-2025 Lack of education causes patients to stop vital treatments, survey finds Cognitant Group Ltd
10-Dec-2025 UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder UCB
09-Dec-2025 Poolbeg Pharma plc - POLB 001 trial to feature in groundbreaking cancer immunotherapy-induced CRS research programme Poolbeg Pharma
05-Dec-2025 7 Million Psoriasis Patients See New Hope: China Launches Its First IL-23p19 Inhibitor Picankibart dengyuemed
04-Dec-2025 Biocair Strengthens Global Network and Sustainability Commitments in 2025 Biocair
04-Dec-2025 Quotient Sciences and Intrepid Labs form strategic partnership to accelerate AI-guided formulation development Quotient Sciences
03-Dec-2025 EHC 2025: Teva’s PEARL Real-World Study Reinforce the Long-term Effectiveness of AJOVY® for the Prevention of Chronic and Episodic Migraine Teva Pharmaceuticals
03-Dec-2025 IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform IQVIA
02-Dec-2025 Charles University selects Mars Bioimaging’s photon-counting CT scanner to advance pioneering preclinical imaging research in Europe MARS Bioimaging
02-Dec-2025 PumasAI’s AskPumas Surpasses 15,000 Questions Answered as Global Use of AI Tools in Drug Development Accelerates PumasAI
02-Dec-2025 Evestia Clinical Announces New Strategic Advisory Board to Advance Specialist CRO Capabilities Worldwide Evestia Clinical
02-Dec-2025 Zelluna ASA Announces Appointment of Geir Christian Melen as New Chief Financial Officer Zelluna ASA